In conclusion, our results show that BI-ALCL has a distinctive cytokine profile, mainly characterized by high levels of IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio, which might represent additional biomarkers to be used in daily clinical practice for screening late seromas. This evidence concerns the gene CACNA1A and anaplastic large cell lymphoma.